chr1-207677460-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_175710.2(CR1L):c.169A>T(p.Ile57Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I57T) has been classified as Uncertain significance.
Frequency
Consequence
NM_175710.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151774Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249214Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135188
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461668Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 727104
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151894Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74206
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2024 | The c.169A>T (p.I57F) alteration is located in exon 2 (coding exon 2) of the CR1L gene. This alteration results from a A to T substitution at nucleotide position 169, causing the isoleucine (I) at amino acid position 57 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at